PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
暂无分享，去创建一个
A. deFazio | P. Beale | F. Amant | K. Tan | L. Mileshkin | M. Friedlander | Y. Antill | C. Kennedy | K. Sjoquist | Alison Davis | O. Mcnally | P. Sykes | T. Bonaventura | P. Grant | Monica Tang | J. Goh | R. O’Connell | J. Scurry | T. Moujaber | O. McNally